Articles tagged "Outcome"

2015 American Transplant Congress
Donor and Recipient Pretransplant Polyoma BK Serostatus: Relationship to BK-Viremia After Renal Transplantation
H. Tseng, R. Lopez-Soler, N. Chandolias, T. Friedrich, J. Eldor, D. Conti.
Surgery, Albany Medical College, Albany, NY.
Background:Polyoma virus BK nephropathy is a serious complication after renal transplantation and is associated with a significant risk of graft loss and dysfunction. This study…
2015 American Transplant Congress
Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience
P. Vaitla, U. Patel, A. Cruz, S. Guisti, A. Moiz, C.-S. Catherine, A. Cohen, G. Loss, H. Bohorquez, I. Carmody, T. Reichman, D. Bruce, S. Anders, J. Garces.
Ochsner Clinic Foundation, New Orleans, LA.
Background:Antibody induction therapy has been used for induction in up to 80% kidney transplant recipients according to United Network for Organ Sharing. It has been…
2015 American Transplant Congress
Analysis of the Temporal Evolution of Causes of Graft Loss Among Kidney Transplant Recipients in a US Southern State
M. Kadian,¹ M. Posadas Salas,¹ M. Kamel,¹ D. Taber,² M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
¹Department of Medicine, Medical University of South Carolina, Charleston, SC; ²Department of Surgery, Medical University of South Carolina, Charleston, SC.
The past decade of kidney transplantation has seen many changes in immunosuppression (IS), donor, and recipient characteristics. This study analyzes the associations between the aforementioned…
2015 American Transplant Congress
Impact of Donor Age on Longterm Outcomes in Asian Kidney Transplant Recipients: A Multicenter Cohort Study
K. Yoo,¹ J. An,² J.-H. Cho,³ C.-D. Kim,³ S.-K. Park,⁴ D.-W. Chae,⁵ Y. Oh,² C. Lim,² Y. Kim,¹ Y. Kim,⁶ J. Lee.²
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea; ²Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; ³Internal Medicine, Kyungpook National University Hospital, Daegu, Korea; ⁴Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; ⁵Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea; ⁶Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.
Background The living donor kidney transplantation (LDKT) is well known for best treatment of end-stage renal disease. Recently, kidney transplantation from elderly living donor has…
2015 American Transplant Congress
Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers
D. Hoyer,¹ A. Gallinat,¹ T. Minor,² F. Saner,¹ P. Kocabayoglu,¹ J. Treckmann,¹ A. Paul.¹
¹General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; ²Surgical Research Division, University Hospital Bonn, Bonn, Germany.
Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…
2015 American Transplant Congress
The Impact of Perioperative Bleeding on Long-Term Outcomes of Mechanical Circulatory Support
K. Lietz,¹ M. Mooney,¹ I. El Lakkis,² C. Derber,² U. Kelly,² C. Wilson,² A. Hoedt,¹ P. Bourassa,¹ B. Smith,¹ M. McGrath,¹ J. Herre.¹
¹Sentara Norfolk General Hospital, Norfolk, VA; ²Eastern Virginia Medical School, Norfolk, VA.
Purpose: Postoperative bleeding is a common complication of MCS surgery. The incidence of bleeding in published series exceeds by several times the 3-5% rates seen…
2015 American Transplant Congress
HLA-DR Matching Improves Immunologic Outcomes in Elderly Kidney Transplant Recipients
F. Halleck, D. Khadzhynov, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.
Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
BACKGROUND: The Eurotransplant senior program (ESP) neglects HLA matching for elderly (>65y) KTR. Only few data exist regarding the influence of HLA-DR-matching on immunologic outcomes.PATIENTS…
2015 American Transplant Congress
Safety and Efficacy of Pegylated Interferon and Ribavirin for Chronic Hepatitis C Following Renal Transplantation
G. Chen, L. Zhu, S. Chen, X. Wang, Z. Lin.
Institute of Organ Transplantation, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Objective We sought to investigate the safety and efficacy of pegylated Interferon (PEG-IFN) and ribavirin for chronic hepatitis C (HCV) following renal transplantation.Methods Ten adult…